View in EDS HTML Full Text PDF Full Text

Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.

Saved in:
Bibliographic Details
Title: Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.
Authors: Shore ND; Carolina Urologic Research Center, 823 82nd Pkwy, Suite B, Myrtle Beach, SC, 29572, USA. NShore@gsuro.com., Mehlhaff BA; Oregon Urology Institute, Springfield, OR, USA., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Saltzstein DR; Urology San Antonio, San Antonio, TX, USA., Tutrone R; Chesapeake Urology, Towson, MD, USA., Brown B; Myovant Sciences, Inc., Brisbane, CA, USA., Lu S; Myovant Sciences, Inc., Brisbane, CA, USA., Fallick M; Myovant Sciences, Inc., Brisbane, CA, USA., Hanson S; Pfizer Inc., New York, NY, USA., Saad F; University of Montreal Hospital Centre, Montreal, QC, Canada.
Source: Advances in therapy [Adv Ther] 2023 Nov; Vol. 40 (11), pp. 4919-4927. Date of Electronic Publication: 2023 Sep 15.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37713020
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shore+ND%22">Shore ND</searchLink>; Carolina Urologic Research Center, 823 82nd Pkwy, Suite B, Myrtle Beach, SC, 29572, USA. NShore@gsuro.com.<br /><searchLink fieldCode="AU" term="%22Mehlhaff+BA%22">Mehlhaff BA</searchLink>; Oregon Urology Institute, Springfield, OR, USA.<br /><searchLink fieldCode="AU" term="%22Cookson+MS%22">Cookson MS</searchLink>; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.<br /><searchLink fieldCode="AU" term="%22Saltzstein+DR%22">Saltzstein DR</searchLink>; Urology San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Tutrone+R%22">Tutrone R</searchLink>; Chesapeake Urology, Towson, MD, USA.<br /><searchLink fieldCode="AU" term="%22Brown+B%22">Brown B</searchLink>; Myovant Sciences, Inc., Brisbane, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lu+S%22">Lu S</searchLink>; Myovant Sciences, Inc., Brisbane, CA, USA.<br /><searchLink fieldCode="AU" term="%22Fallick+M%22">Fallick M</searchLink>; Myovant Sciences, Inc., Brisbane, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hanson+S%22">Hanson S</searchLink>; Pfizer Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Saad+F%22">Saad F</searchLink>; University of Montreal Hospital Centre, Montreal, QC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2023 Nov; Vol. 40 (11), pp. 4919-4927. <i>Date of Electronic Publication: </i>2023 Sep 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37713020
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-023-02634-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4919
    Titles:
      – TitleFull: Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shore ND
      – PersonEntity:
          Name:
            NameFull: Mehlhaff BA
      – PersonEntity:
          Name:
            NameFull: Cookson MS
      – PersonEntity:
          Name:
            NameFull: Saltzstein DR
      – PersonEntity:
          Name:
            NameFull: Tutrone R
      – PersonEntity:
          Name:
            NameFull: Brown B
      – PersonEntity:
          Name:
            NameFull: Lu S
      – PersonEntity:
          Name:
            NameFull: Fallick M
      – PersonEntity:
          Name:
            NameFull: Hanson S
      – PersonEntity:
          Name:
            NameFull: Saad F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1